Hangzhou Yingde Gas
Corporate Round in 2024
Hangzhou Yingde Gas is a company that specializes in the manufacturing and sales of industrial automatic control system devices and electrical signal equipment.
Soterea is a software company based in Tianjin, China, specializing in the development of intelligent driving systems for commercial vehicles. Founded in 2014, the company focuses on enhancing driving safety through advanced technology. Soterea's offerings include high-precision sensing systems, automatic braking solutions, and a cloud platform designed to assist drivers in navigating safely and preventing accidents. By integrating these technologies, Soterea aims to transform the safety standards in the commercial driving sector.
Rain Med is a vascular interventional surgical robot developer focused on the development of coronary angiography systems.
Xgene Pharmaceutical
Series C in 2021
Xgene Pharmaceutical Inc. is a pharmaceutical company founded in 2015 and based in the Cayman Islands. It focuses on developing small-molecule drugs aimed at treating chronic pain, infectious diseases, and tumors, with a particular emphasis on neurological disorders. As a late-clinical stage, venture-backed firm, Xgene utilizes proprietary linker technology to create novel, multimodal conjugated molecules. Its current programs are designed to enhance the efficacy and tolerability of pain medications, addressing unmet needs in the treatment of chronic pain and neurological conditions.
Biren Technology
Series B in 2021
Biren Technology is a high-tech startup specializing in the design and development of intelligent processors tailored for GPU and DSA computation architectures. The company focuses on creating integrated software and hardware platforms that support intelligent computing applications, including cloud computing, artificial intelligence training, graphics rendering, and high-performance general-purpose computing. With a dedicated team of industry experts and elite engineers, Biren Technology aims to deliver versatile computing solutions that blend general computing capabilities with specific applications. Its research division is committed to advancing key technologies in intelligent computing systems, emphasizing new architectures and advanced compilation techniques, thereby facilitating technological breakthroughs in various high-tech sectors.
MitrAssist
Venture Round in 2020
MitrAssist is a medical device company focused on addressing mitral valve regurgitation (MR) through an innovative and minimally invasive approach. The company has developed a proprietary mitral valve implant that complements the natural mitral valve rather than replacing or repairing it. This unique "valve-in-valve" technique enhances the functionality of the existing valve, providing an effective treatment option for patients suffering from MR. MitrAssist's implant is designed to address the challenges associated with MR, offering a solution that surpasses current minimally invasive alternatives. By prioritizing patient health and comfort, MitrAssist aims to significantly improve treatment outcomes for individuals with this condition.
Apollomics
Series C in 2020
Apollomics, Inc. is an emerging life sciences company based in Foster City, California, focused on developing innovative oncology therapies aimed at targeting the growth and proliferation of cancer cells. Founded in 2016, the company’s pipeline includes several development-stage assets, such as CBT-101, an oral agent that targets the epithelial to mesenchymal transition pathway associated with various tumors, and CBT-102, which inhibits the MAP Kinase pathway and angiogenesis through its effects on specific receptors. Additionally, Apollomics is advancing monoclonal antibodies CBT-501 and CBT-502, which target the PD-1 and PDL-1 membrane receptors, respectively, to enhance the immune response against cancer. By combining immune-based strategies with targeted therapies, Apollomics aims to develop novel treatments that can effectively combat cancer.
Lepu Biotechnology Co., Ltd. is a Chinese biotech company specializing in tumor immunotherapy. Founded in 2018, it has developed an industrial platform dedicated to target discovery, drug preparation, development, and manufacturing. The company focuses on creating drug candidates that include programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) antibodies, an oncolytic virus, and various antibody-drug conjugates (ADCs). Lepu Bio's core products are currently in clinical stages I to III, demonstrating its commitment to advancing cancer treatment through innovative biopharmaceutical solutions.
DentaLink China
Series C in 2020
Developer of dental imaging technology and dental clinic management software. The company's software helps dental professionals accurately diagnose patient conditions through oral CT scanning, as well as keep track of patient records and appointments, enabling dental professionals to provide treatment more efficiently.
Wind
Funding Round in 2019
Wind Information is recognized as the leading firm in financial data, information services and solutions in China. We are dedicated to providing accurate and real-time data, as well as sophisticated information platforms for financial professionals.
Lixiangjia
Series D in 2019
The professional global Chinese overseas asset reconfiguration consulting service platform is dedicated to providing one-stop overseas asset product information support services for Chinese wealth management practitioners. It has set up branches in many cities across the country to provide institutions, financial planners and medium and high net worth families. Professional overseas asset reconfiguration plan.
Shijiazhuang Junlebao Dairy
Funding Round in 2019
Shijiazhuang Junlebao Dairy is a prominent dairy products company based in China, specializing in the production and sale of a diverse array of dairy items. Its product offerings include fluid milks, flavored milk, baby formula, yogurt, and milk powder. The company has developed a comprehensive operational framework that spans the entire dairy industry chain, focusing on coordinated development, nutrition, health, and safety for consumers. Through its commitment to quality and innovation, Shijiazhuang Junlebao Dairy aims to meet the evolving needs of its customers while promoting health and wellness in the dairy sector.
iTutorGroup
Acquisition in 2019
iTutorGroup is an online education provider founded in 1998, headquartered in Taipei City, Taiwan, with additional offices in Shanghai, China, and Santa Clara, California. The company offers a range of platforms designed for both students and business professionals, including VIPABC, TutorABC, VIPABCJr, and TutorABCJr for English language learning, as well as TutorMing for Mandarin Chinese language instruction. Additionally, iTutorGroup provides LiveH2H, a service for live translations in multiple languages. The company focuses on delivering individualized and personalized learning experiences, allowing instructors to tailor content to meet the specific needs of learners.
Lenovo Healthcare Information Technology (Lenovo HIT)
Corporate Round in 2019
Lenovo Healthcare is a cloud-based smart medical solution company for medical institutions.
Global Data Solutions
Post in 2019
Global Data Solutions Limited is a prominent data center operator based in Shanghai, China, with additional facilities in Beijing, Chengdu, Shenzhen, Kunshan, and Guangzhou. Founded in 2000 by William Wei Huang, the company specializes in designing, building, and managing data centers while offering a range of information technology outsourcing services across the Asia-Pacific region. Its offerings include colocation, managed hosting, managed cloud services, and comprehensive consulting services. Global Data Solutions caters to a diverse clientele, including government agencies and industries such as finance, energy, manufacturing, aviation, telecommunications, and information technology. The company is particularly focused on serving customers in the Internet and banking sectors, providing essential business continuity and disaster recovery solutions, along with operational monitoring and testing services.
Zhangshang Tangyi
Series C in 2019
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.
Xiaoqule is a community-focused e-commerce platform headquartered in Hangzhou, China, and operates as a subsidiary of Zhejiang Gejia Network Technology Co., Ltd. The company connects local businesses with consumers, enabling the provision of cost-effective products and services tailored to community needs. Through its platform, users can order a variety of items, including seasonal fruits, vegetables, and imported snacks, while also benefiting from group ordering options. Xiaoqule emphasizes convenience by shortening transportation times and ensuring the quality of goods. Additionally, the platform offers logistical support, encompassing transportation, technology, marketing, and customer service, thereby facilitating interactions within the community and enhancing the overall shopping experience.
Global Scanner
Series A in 2018
Global Scanner is a social e-commerce platform targeting the middle-class in China.
NextCure, Inc. is a clinical-stage biopharmaceutical company based in Beltsville, Maryland, that focuses on discovering and developing novel immunomedicines aimed at treating cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate, NC318, is currently undergoing Phase 2 clinical trials for advanced or metastatic solid tumors. Additionally, NextCure is developing NC410, designed to inhibit immune suppression through the modulation of a specific immune receptor. The company is also advancing other product candidates, including LNCB74, an antibody-drug conjugate targeting B7-H4, and is exploring additional immunomodulatory molecules in preclinical stages. NextCure has established collaborations with Yale University for licensing and with Eli Lilly and Company for research and development. Founded in 2015, the company leverages proprietary platforms to identify biologically relevant targets in its pursuit of first-in-class immunotherapy solutions.
Xgene Pharmaceutical
Series B in 2018
Xgene Pharmaceutical Inc. is a pharmaceutical company founded in 2015 and based in the Cayman Islands. It focuses on developing small-molecule drugs aimed at treating chronic pain, infectious diseases, and tumors, with a particular emphasis on neurological disorders. As a late-clinical stage, venture-backed firm, Xgene utilizes proprietary linker technology to create novel, multimodal conjugated molecules. Its current programs are designed to enhance the efficacy and tolerability of pain medications, addressing unmet needs in the treatment of chronic pain and neurological conditions.
Lenovo Healthcare Information Technology (Lenovo HIT)
Series A in 2018
Lenovo Healthcare is a cloud-based smart medical solution company for medical institutions.
Jinjiang Environment
Post in 2018
Jin Jiang Environmental Holdings Limited is China's leading waste to energy operators.The company has successfully embarked on a road of environmentally-friendly energy industrialization that combines production, learning
Grab Financial Group
Venture Round in 2018
Grab Financial Group provides financial services across payments, rewards, lending, and insurance. A seamless point-of-sale (POS) system for merchants and a trusted mobile wallet of choice in Southeast Asia for payments such as in-store purchases, Grab transactions, and fund transfers.
Grab Holdings Inc., headquartered in Singapore, operates a mobile technology platform that integrates city transportation and various on-demand services in Southeast Asia. The company, founded in 2012 by Anthony Tan and Tan Hooi Ling, offers services such as ride-hailing (GrabTaxi, GrabCar), carpooling (GrabHitch, GrabShare), shuttle services (GrabShuttle, GrabShuttle Plus), and food delivery through its GrabFood platform. Grab also provides financial services, including payments, consumer loans, and enterprise offerings. It operates in eight countries: Singapore, Indonesia, Philippines, Malaysia, Thailand, Vietnam, and Myanmar. Grab generates revenue by charging commissions to both consumers and service providers, with ride-hailing and food delivery contributing to 89% of its total revenue. The company competes with Foodpanda and Gojek in the region.
Chemclin
Private Equity Round in 2018
Chemclin Biotech is a Chinese technical service provider specializing in in-vitro diagnostic instruments and auxiliary reagents for clinical diagnosis. The company develops, produces, and sells clinical immunochemiluminescence diagnostic testing reagents and instruments. Its service offerings encompass clinical inspection instruments, various types of auxiliary reagents, technical support, management and certification, as well as the operation of independent medical laboratories. Chemclin is committed to introducing advanced diagnostic products and services to the Chinese market, thereby enhancing the capabilities of clinical diagnostics in the region.
HashFish
Angel Round in 2018
HashFish provides bitcoin mining software and services.
JollyChic
Series C in 2018
JollyChic is a comprehensive e-commerce platform founded in 2012 by Aaron Li, headquartered in China. It specializes in the online retail of a diverse range of consumer products, including clothing, accessories, electronics, home goods, baby products, and more. The platform aims to provide customers with a variety of quality and stylish items, catering to various needs and preferences. By facilitating cross-border transactions, JollyChic enables shoppers to access suitable offers while ensuring decent quality in the products available for purchase.
Tmunity Therapeutics, Inc. is a biotherapeutics company based in Philadelphia, Pennsylvania, that specializes in the development of innovative immunotherapies for cancer, infectious diseases, and autoimmune disorders. Founded in 2015, Tmunity focuses on harnessing the potential of T cells through novel technologies, including T Cell Receptor (TCR) engineered T cells and regulatory T cells (Treg). The company has developed advanced platforms that allow for precise control over T cell activation and direction in vivo, as well as proprietary methods for activating, expanding, and genetically engineering T cells sourced from peripheral blood, cord blood, and tumors. Tmunity aims to advance personalized next-generation immunotherapies and has a team of experts with extensive experience in T-cell biology and clinical development, enhancing its capability to conduct safe and effective clinical trials. Its robust manufacturing platform supports multi-center clinical studies across various therapeutic areas, positioning Tmunity at the forefront of immunotherapy innovation.
Hua Medicine
Series D in 2018
Hua Medicine, established in 2009, is a Shanghai-based clinical-stage drug development company. It specializes in therapies for diabetes and central nervous system (CNS) disorders in China. The company's primary focus is Dorzagliatin, an oral drug for Type 2 diabetes, which is in Phase 3 clinical trials, both as a standalone treatment and in combination with metformin. Additionally, Hua Medicine is developing Dorzagliatin in combination with other drugs and mGLUR5 for Parkinson's disease levodopa-induced dyskinesia, both in pre-clinical stages. The company's mission is to address unmet medical needs in China through innovative drug development.
Rani Therapeutics
Venture Round in 2018
Rani Therapeutics, LLC is a clinical-stage biotherapeutics company focused on developing oral delivery systems for large drug molecules, including peptides, proteins, and antibodies. The company has created the RaniPill capsule, a novel and patented technology designed to replace traditional subcutaneous or intravenous injections with an oral dosing method. This capsule is engineered to automatically release a precise therapeutic dose of medication in the small intestine, aiming to enhance patient compliance and comfort. Rani Therapeutics has conducted several preclinical and clinical studies to assess the safety, tolerability, and bioavailability of the RaniPill, contributing to a robust intellectual property portfolio. The company's therapeutic offerings include treatments for inflammatory disorders, osteoporosis, growth deficiencies, and multiple sclerosis, among others. Founded in 2012 and based in San Jose, California, Rani Therapeutics seeks to improve patient outcomes by providing a convenient alternative to painful injections.
TytoCare Ltd. is a healthcare technology company that specializes in developing handheld devices and mobile applications for remote medical examinations. Founded in 2011 and headquartered in Netanya, Israel, with an additional office in New York, TytoCare enables users to perform self-examinations and connect with healthcare professionals for on-demand diagnoses and prescriptions. The company's product offerings include TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care settings. These solutions encompass a modular examination tool that allows users to assess various health parameters, including heart and lung function, skin, throat, ears, and body temperature. TytoCare's platform also features a telehealth system for sharing examination data, conducting live video consultations, and utilizing a cloud-based repository with analytics. With built-in guidance technology and machine learning, TytoCare aims to enhance the accuracy and accessibility of healthcare services. The company maintains a strategic partnership with Novant Health to further its mission of facilitating remote healthcare.
Tmunity Therapeutics, Inc. is a biotherapeutics company based in Philadelphia, Pennsylvania, that specializes in the development of innovative immunotherapies for cancer, infectious diseases, and autoimmune disorders. Founded in 2015, Tmunity focuses on harnessing the potential of T cells through novel technologies, including T Cell Receptor (TCR) engineered T cells and regulatory T cells (Treg). The company has developed advanced platforms that allow for precise control over T cell activation and direction in vivo, as well as proprietary methods for activating, expanding, and genetically engineering T cells sourced from peripheral blood, cord blood, and tumors. Tmunity aims to advance personalized next-generation immunotherapies and has a team of experts with extensive experience in T-cell biology and clinical development, enhancing its capability to conduct safe and effective clinical trials. Its robust manufacturing platform supports multi-center clinical studies across various therapeutic areas, positioning Tmunity at the forefront of immunotherapy innovation.
Kbp Biosciences
Series A in 2018
KBP Biosciences is a biotechnology research and development organization focused on creating innovative therapies for unmet medical needs, particularly in the fields of cardiovascular, respiratory, inflammatory, and autoimmune diseases. The company is dedicated to the research, development, and commercialization of novel medicines, leveraging new drug development ideas alongside its own medicinal chemistry expertise. With a strong emphasis on clinical development and regulatory compliance, KBP Biosciences aims to empower healthcare providers by offering effective treatments to improve patient outcomes in areas where existing therapeutic options are limited.
StartUp Health
Venture Round in 2018
StartUp Health, founded in 2011 and based in San Francisco, is a venture capital investment firm dedicated to improving global health and wellbeing. The firm collaborates with a network of entrepreneurs known as Health Transformers to pursue ambitious health goals, referred to as health moonshots. These include improving access to care, reducing costs, curing diseases, addressing various health issues such as cancer, women's and children's health, nutrition and fitness, brain health, mental health, addiction, longevity, and pandemic response. StartUp Health boasts the largest health innovation portfolio in the world, comprising over 330 companies across 26 countries and six continents. The firm is supported by a diverse range of prominent investors from the healthcare and technology sectors, reflecting its commitment to fostering innovation in health.
Beijing Rogrand Electronic Commerce Co., Ltd. is a private company established in 2012, specializing in medical e-commerce integrated services in China. The firm operates as a comprehensive service platform that encompasses the entire pharmaceutical industry chain, facilitating connections among pharmaceutical companies, pharmacies, clinics, and medical institutions. Rogrand aims to innovate within the pharmaceutical sector by providing a circulation platform that enhances the efficiency and effectiveness of medical commerce, ultimately contributing to the overall advancement of healthcare services in the region.
Chexiang is a Chinese online-to-offline automotive trading platform operated by Shanghai-based SAIC Motor Co. Ltd. The platform is designed to serve the automotive needs of consumers in China, offering services that include renting, buying, sharing, or booking vehicles at competitive prices. By facilitating these transactions, Chexiang aims to enhance the travel experience for its users, providing convenient access to various automotive options.
Fullerton Healthcare Corporation
Venture Round in 2017
Fullerton Health is a prominent provider of corporate healthcare solutions in the Asia Pacific region, operating a network of over 225 fully-owned medical centres and more than 8,000 medical providers. Headquartered in Singapore, the company employs around 2,000 individuals, including over 1,200 healthcare professionals. Fullerton Health specializes in managed care, network management, primary care, and secondary care, ensuring that patients receive efficient and cost-effective healthcare services. The organization also operates six call centres across five countries, enhancing its capability to deliver comprehensive support and services to its clients.
Tikin Media
Angel Round in 2017
Tikin Media is an innovative advertising company that specializes in elevator marketing solutions, connecting properties with advertisers. It focuses on creating high-end commercial building media experiences through the installation of advanced projector systems in elevators. This unique approach offers advertisers a new channel to engage consumers, enhancing product visibility in a novel environment. The company has developed proprietary elevator projection equipment, which integrates mobile connectivity, programmatic ordering, and big data analytics, thus transforming traditional advertising methods. With backing from prominent investors, Tikin Media aims to redefine the landscape of advertising within commercial spaces.
MitrAssist
Venture Round in 2017
MitrAssist is a medical device company focused on addressing mitral valve regurgitation (MR) through an innovative and minimally invasive approach. The company has developed a proprietary mitral valve implant that complements the natural mitral valve rather than replacing or repairing it. This unique "valve-in-valve" technique enhances the functionality of the existing valve, providing an effective treatment option for patients suffering from MR. MitrAssist's implant is designed to address the challenges associated with MR, offering a solution that surpasses current minimally invasive alternatives. By prioritizing patient health and comfort, MitrAssist aims to significantly improve treatment outcomes for individuals with this condition.
Annoroad Gene Technology, established in 2012 and headquartered in Beijing, is a prominent player in China's genomics industry, recognized as a leading provider of non-invasive prenatal testing (NIPT) and a distinguished medical genomics center in Asia. The company specializes in the application of next-generation sequencing technologies for human health and life science research. Annoroad has received numerous accolades, including recognition as a national high-tech enterprise and approval as a pilot organization by the National Health and Family Planning Commission for high-throughput sequencing clinical applications. With advanced proprietary genome sequencing and bioinformatics technologies, Annoroad offers a comprehensive range of services, including the NextSeq 550AR sequencer and NIPT reagent kits, facilitating diagnostic applications in human reproduction, cancer, and rare diseases. The company has established a robust presence across the entire genomics industry chain, supported by a strong talent pool and powerful bioinformatics capabilities, earning a high reputation among partners in the field.
Prenetics
Series B in 2017
Prenetics Limited is a DNA biotechnology company based in Central, Hong Kong, specializing in pharmacogenomics and health sciences. The company offers the iGenes PGx test, which assists physicians in determining the appropriate medication and dosage for patients based on their genetic profiles while identifying potential adverse drug effects. In addition to pharmacogenomics, Prenetics provides ONEdna, a DNA screening service that delivers insights and actionable recommendations based on an individual’s genetic makeup. Its consumer health initiative is represented by the IM8 brand, while the clinical division includes Insighta, which focuses on multi-cancer early detection technologies, and ACT Genomics, known for its FDA-approved genomic profiling of solid tumors. Prenetics has formed strategic partnerships with notable organizations, including The Lippo Group and New Horizon Health Limited. The company was established in 2007 and underwent a name change from Multigene Diagnostics Limited to Prenetics Limited in November 2014.
Che Youyuan
Series A in 2017
Che Youyuan provides assistance services to the majority of car owners at any time, any place, and any vehicle. Rescue service products and peripheral products include towing service, telephone service, tire replacement service, field repair, dianbao, multi tool pen, and rescue t-shirt
Huya Inc. operates a leading game live streaming platform in China, facilitating interactive broadcasts that allow real-time interaction between broadcasters and viewers. Founded in 2011 and headquartered in Guangzhou, Huya provides a diverse array of live streaming content, encompassing a vast library of approximately 3,800 games across various genres, including esports, mobile, and console games, as well as entertainment categories like talent shows and online theater. Additionally, Huya runs Nimo TV, which focuses on game streaming in Southeast Asia and Latin America. The company also engages in online advertising, marketing services, software development, and internet value-added services. As a subsidiary of Tencent, Huya benefits from the support of one of the largest technology companies in China, with Tencent holding a significant equity stake and voting power.
Aiqi Technology
Series A in 2017
Beijing AIQI Technology Co., Ltd. is an Internet technology company focused on the research and development of artificial intelligence and robotic technologies. The company has assembled a dynamic team of innovative and ambitious individuals dedicated to advancing the field. Over the past three years, Aiqi Technology has secured numerous patents related to intelligent equipment. It has established a partnership with the technology giant Xiaomi, becoming the sole provider of DIY intelligent robots within Xiaomi's ecosystem. The company specializes in the development of interactive DIY family robots designed for K-12 STEM education, offering users engaging human-machine interaction experiences. With a strong research team and advanced technology, Aiqi Technology aims to inspire creativity and provide enjoyable, easy-to-use products that enhance modern life.
Global Switch Holdings
Secondary Market in 2016
Global Switch Holdings Limited, established in 1998, is a leading provider of data center services, operating in Europe and the Asia-Pacific region. The company owns and manages a portfolio of thirteen, multi-tenant, carrier and cloud-neutral data centers, totaling approximately 390,000 square meters of technical space. These facilities offer secure, high-quality infrastructure and environmental monitoring services, housing computer servers, network equipment, and IT infrastructure for a diverse range of clients, including government organizations, financial institutions, enterprises, and global systems integrators. Global Switch's data centers are strategically located in prime city locations and internet hubs, ensuring low latency and high connectivity.
TapTap is an online platform dedicated to gaming enthusiasts, serving as both a community hub and a marketplace for game downloads and purchases. It facilitates interaction among users while providing access to a diverse range of games, catering to various interests and preferences within the gaming community. By combining social features with a robust selection of games, TapTap aims to enhance the gaming experience and foster connections among players.
Innovent Biologics
Series D in 2016
Innovent Biologics, Inc. is a prominent biopharmaceutical company based in Suzhou, China, specializing in the discovery, development, manufacturing, and commercialization of monoclonal antibodies. The company focuses on therapeutic areas such as oncology, ophthalmology, immunology, and metabolic diseases. Its flagship product, Tyvyt (sintilimab), is an anti-PD-1 monoclonal antibody approved for treating various cancers, including Hodgkin's lymphoma and esophageal carcinoma. Innovent's pipeline includes several important candidates, such as IBI-301, a rituximab biosimilar for non-Hodgkin's lymphoma, and IBI-303, an adalimumab biosimilar for autoimmune diseases. The company is also developing innovative therapies for conditions like hypercholesterolemia and various cancers. With a robust portfolio of commercialized products and ongoing strategic collaborations with major pharmaceutical companies, Innovent aims to expand its impact in the global biopharmaceutical landscape. Founded in 2011, Innovent is recognized as one of China's leading biotechnology firms.
Gegejia.com
Series A in 2016
Gegejia, operated by Zhejiang Grid Network Technology Co., Ltd., is an e-commerce platform specializing in the sale of imported food products. Launched on March 26, 2015, the company quickly gained traction, processing over 10,000 orders within its first 30 days, generating millions in revenue. Gegejia partners with renowned international food brands to offer high-quality and carefully selected food items to Chinese consumers. The core team at Gegejia brings extensive e-commerce experience, with each member having between five to ten years in the industry, contributing to the company's strong resource network and operational expertise.
Fe3 Medical
Series B in 2016
Fe3 Medical, Inc., also known as Bria Medical, specializes in developing transdermal therapies aimed at treating iron deficiency anemia. The company has created a disposable transdermal patch designed to deliver a precise amount of iron directly through the skin, effectively bypassing the gastrointestinal tract and minimizing associated side effects. This innovative approach primarily targets women affected by iron deficiency. Established in 2008, Fe3 Medical is headquartered in San Antonio, Texas, and focuses on the commercialization of its drug delivery technology, which safely transports approximately 10 milligrams of iron through the skin for patients in need.
Nanopep
Seed Round in 2016
Nanopep is a nano-biomedical company specializing in high-tech solutions for cancer prevention and precision medicine. It develops advanced platform technologies, including SPRI and MALDI-TOF MS microarrays, which facilitate massively parallel peptide screening. Additionally, Nanopep has created an efficient platform for enriching circulating tumor cells using nano-beads, which underpins its protein-based liquid biopsy assay. The company's innovations cater to three primary user groups: they provide preventative detection services for healthy individuals, assess and identify risks for patients with tumors, and offer treatment options for patients expressing PD-L1. Through its focus on personalized medicine and cutting-edge nano-medicine technologies, Nanopep aims to enhance cancer diagnostics and treatment.
Wanjia
Angel Round in 2016
Wanjia provides dentistry, chinese medicine, pediatrics, and gynaecology services. They provide services for children and adults. Their customers' inquiries are addressed through phone, email, and online applications.
Zhuanhua Yixue Wang
Series A in 2016
Zhuanhua Yixue Wang is a translational medicine portal for gene testing, cell therapy, in vitro diagnosis, precision medicine, and other core segments of translational medicine that provide original content and in-depth industry analysis. They provide news reports for doctors, researchers, enterprises, and related practitioners with the goal of leading the development of the industry. They offer services for forums, salons, and training courses.
Fabric Genomics (formerly Omicia)
Series B in 2016
Fabric Genomics is making genomics-driven precision medicine a reality. We provide clinical decision support software that enables clinical labs, hospital systems and country-sequencing programs to gain actionable genomic insights, resulting in faster and more accurate diagnoses and reduced turnaround time. Fabric’s end-to-end genomic analysis platform incorporates proven AI algorithms, and has applications in both hereditary disease and oncology. Headquartered in Oakland, California, Fabric Genomics was founded by industry veterans and innovators with a deep understanding of bioinformatics, large-scale genomics and clinical diagnostics.
Applied StemCell
Series D in 2016
Applied StemCell Inc. is a biotechnology company specializing in the development of animal and cell line models for drug discovery and diagnostics. The company utilizes its proprietary TARGATT™ gene modification technology to create site-specific Knockin mouse, rat, and human cell line models, making the process efficient for both pharmaceutical and academic researchers. Applied StemCell's offerings include a range of genetically modified models, such as Knockin, Knockout, and transgenic mice, as well as humanized mouse models and gene-modified induced pluripotent stem cells (iPSCs). In addition to model development, the company provides optimized stem cell culture products and gene engineering services for mammalian cells. By continuously enhancing its technologies and product lines, Applied StemCell aims to meet the evolving needs of the biomedical community and support advancements in molecular diagnostics and personalized medicine.
Beijing Rogrand Electronic Commerce Co., Ltd. is a private company established in 2012, specializing in medical e-commerce integrated services in China. The firm operates as a comprehensive service platform that encompasses the entire pharmaceutical industry chain, facilitating connections among pharmaceutical companies, pharmacies, clinics, and medical institutions. Rogrand aims to innovate within the pharmaceutical sector by providing a circulation platform that enhances the efficiency and effectiveness of medical commerce, ultimately contributing to the overall advancement of healthcare services in the region.
Shenchu Jia Yan
Angel Round in 2016
Shenchu Jia Yan is an online restaurant reservation platform.
Shanghai F-Road Commercial Services Co., Ltd. specializes in mobile financial services tailored for financial institutions. Founded in 2008 and based in Shanghai, the company offers a variety of services, including encrypted mobile banking, online daily transactions, community bank development, and asset management for regional banks. F-Road focuses on enhancing the capabilities of regional banks and rural financial organizations through its advanced technology solutions, which incorporate big data, cloud platforms, and artificial intelligence. The company provides two platform services—a local life platform and a smart credit platform—alongside an eID operation service to facilitate the transformation and upgrading of financial institutions. F-Road is committed to promoting inclusive finance and improving financial accessibility in underserved areas.
AutoHome
Acquisition in 2016
Autohome Inc. is the leading online destination for automobile consumers in China, established in 2008 as a media content platform. It operates two primary websites, autohome.com.cn and che168.com, which offer extensive, independent, and interactive content tailored for automobile buyers and owners. The platform ranks first among automotive service sites in terms of mobile daily active users and has a significant market presence, holding a 30% share in online automotive advertising and lead generation services. Autohome's extensive user base makes it an attractive platform for automakers and dealers, who utilize its advertising services for brand promotion, new model launches, and sales campaigns. Additionally, its dealer subscription services enable dealers to effectively market their inventory and services, significantly broadening the reach of their physical showrooms to millions of potential customers across China.
Meidaila1221
Series B in 2016
Meidaila is a computer software company offering technology solutions.
Prenetics
Series A in 2016
Prenetics Limited is a DNA biotechnology company based in Central, Hong Kong, specializing in pharmacogenomics and health sciences. The company offers the iGenes PGx test, which assists physicians in determining the appropriate medication and dosage for patients based on their genetic profiles while identifying potential adverse drug effects. In addition to pharmacogenomics, Prenetics provides ONEdna, a DNA screening service that delivers insights and actionable recommendations based on an individual’s genetic makeup. Its consumer health initiative is represented by the IM8 brand, while the clinical division includes Insighta, which focuses on multi-cancer early detection technologies, and ACT Genomics, known for its FDA-approved genomic profiling of solid tumors. Prenetics has formed strategic partnerships with notable organizations, including The Lippo Group and New Horizon Health Limited. The company was established in 2007 and underwent a name change from Multigene Diagnostics Limited to Prenetics Limited in November 2014.
Fe3 Medical
Series B in 2016
Fe3 Medical, Inc., also known as Bria Medical, specializes in developing transdermal therapies aimed at treating iron deficiency anemia. The company has created a disposable transdermal patch designed to deliver a precise amount of iron directly through the skin, effectively bypassing the gastrointestinal tract and minimizing associated side effects. This innovative approach primarily targets women affected by iron deficiency. Established in 2008, Fe3 Medical is headquartered in San Antonio, Texas, and focuses on the commercialization of its drug delivery technology, which safely transports approximately 10 milligrams of iron through the skin for patients in need.
JMDNA (Shanghai) Bio-Medical Technology Co., Ltd. is a high-tech enterprise founded in 2011 and based in Shanghai, China, specializing in molecular diagnostics. The company focuses on research and application services that cater specifically to the health needs of women and children. JMDNA offers comprehensive and precise genetic testing services, including non-invasive genetic tests, diagnostics for liver diseases and tumors, and the detection of hereditary conditions. By enabling early diagnosis of various medical conditions, JMDNA aims to enhance healthcare outcomes for mothers and children, collaborating with medical institutions and industry partners to advance clinical applications in this field.
Yunda Express
Private Equity Round in 2016
Yunda Express, officially known as Yunda Holding Co., Ltd., is a private express delivery company based in Shanghai, China. Founded in 2003, it specializes in providing integrated logistics services, including express delivery and franchise operations. The company was previously named Ningbo Xinhai Electric Co., Ltd. before rebranding in January 2017. Yunda Express has established a significant presence in the Chinese logistics market, focusing on efficient and reliable delivery solutions.
Rani Therapeutics
Venture Round in 2016
Rani Therapeutics, LLC is a clinical-stage biotherapeutics company focused on developing oral delivery systems for large drug molecules, including peptides, proteins, and antibodies. The company has created the RaniPill capsule, a novel and patented technology designed to replace traditional subcutaneous or intravenous injections with an oral dosing method. This capsule is engineered to automatically release a precise therapeutic dose of medication in the small intestine, aiming to enhance patient compliance and comfort. Rani Therapeutics has conducted several preclinical and clinical studies to assess the safety, tolerability, and bioavailability of the RaniPill, contributing to a robust intellectual property portfolio. The company's therapeutic offerings include treatments for inflammatory disorders, osteoporosis, growth deficiencies, and multiple sclerosis, among others. Founded in 2012 and based in San Jose, California, Rani Therapeutics seeks to improve patient outcomes by providing a convenient alternative to painful injections.
Oscar Health
Private Equity Round in 2016
Oscar Health is a health insurance company based in New York, founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser. It specializes in offering individual and family health insurance plans, Medicare Advantage programs for seniors, and small group products. Oscar Health aims to enhance the healthcare experience by leveraging technology, design, and data to make services more accessible and user-friendly. The company primarily serves individuals, couples, and families who do not receive employer-sponsored health insurance in select states, including New York, New Jersey, California, and Texas. In addition to traditional insurance offerings, Oscar provides virtual care, doctor support, and appointment scheduling, emphasizing a comprehensive approach to healthcare management.
YICHUAN
Angel Round in 2016
YICHUAN is a men's lifestyle media services company.
Bochewang
Series B in 2016
Bochewang operates as a professional B2B trading platform focused on motor cars and accessories, catering specifically to professional buyers such as auto repair shops, dismantle shops, used car dealers, and parts sellers. The platform features three primary components: an auction center for selling accident and used vehicles, an automobile showroom for trading repaired cars, and an accessories platform for various auto parts. By facilitating online transactions, Bochewang aims to streamline the buying and selling process for car owners and buyers, enhancing efficiency while reducing the time involved in these transactions. Users can access a variety of services and rights upon completing registration, payment, and authentication on the platform.
20/20 Gene Systems
Series A in 2016
20/20 GeneSystems Inc. is a biotechnology company based in Rockville, Maryland, focused on developing and commercializing diagnostic tests for the early detection of cancer. The company offers several products, including PAULA’s Test, a blood test for lung cancer detection, and OneTest, which screens for multiple cancer types, such as lung, liver, and pancreatic cancers. Additionally, 20/20 provides BioCheck, a detection kit for screening suspicious powders, and Layered ImmunoHistoChemistry, which predicts the efficacy of targeted cancer therapies. The firm also offers CoronaCheck Tests, specializing in COVID-19 antibody testing. With a commitment to reducing cancer mortality, 20/20 GeneSystems employs advanced biomarker technologies and collaborates with various health agencies and organizations to enhance cancer diagnostics and promote personalized medicine.
Zhangshang Tangyi
Series B in 2016
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.
Xieche.com
Series B in 2016
Xieche.com is a company specializing in automobile maintenance and repair services for car owners. It offers a range of services that include sheet metal painting, electromechanical repairs, air conditioning efficiency improvements, oil changes, and tire rim cleaning. Xieche aims to educate customers about the maintenance processes, enhancing transparency and enabling car owners to better understand how to maintain their vehicles. The company provides both at-home maintenance services and repair options at their physical locations, catering to the diverse needs of car owners.
Kangzhi Pifuyisheng
Series A in 2015
Kangzhi Pifuyisheng is an online consultation service platform.
Alchemy Information
Angel Round in 2015
Alchemy Information is a provider of game art outsourcing services tailored for the gaming industry. The company specializes in 3D art production, animation, and visual effects for various platforms, including PC, AAA consoles, and mobile devices. With a commitment to delivering high-quality game entertainment products, Alchemy Information supports game development companies by offering expertise in both 3D and 2D art and animation.
Black & White Campus
Series A in 2015
Black & White Campus is a company focused on enhancing student engagement through its mobile social application. The app serves as a platform for students to connect, discuss various topics, and organize meetups. Additionally, the company specializes in campus promotion activities, facilitating events and initiatives that foster community interaction and collaboration among students. By addressing the social needs of the student population, Black & White Campus aims to create a vibrant and connected campus experience.
MOGU is an online fashion and lifestyle platform based in China, primarily targeting women. The company offers a diverse array of fashion content and products through its various platforms, including Mogujie.com, Meilishuo.com, and Mogu.com, as well as mobile applications and WeChat Mini programs. MOGU enables users to discover and share the latest fashion trends while enjoying an enhanced shopping experience. The platform features multimedia content such as live video broadcasts, short-form videos, and photography, catering to a wide range of interests and age groups. In addition to its e-commerce offerings, MOGU provides online marketing, commission services, and technology support to merchants and brands, thereby facilitating a comprehensive ecosystem for both consumers and businesses within the fashion industry.
Anxin Doctor
Series A in 2015
Anxin Doctor is a mobile health platform focused on maternal and pediatric care, designed to connect patients with obstetricians, gynecologists, and pediatricians. The platform provides a mobile application that facilitates access to healthcare advice and allows users to book clinical appointments with healthcare professionals. By enhancing communication between patients and doctors, Anxin Doctor aims to improve health outcomes for mothers and children, making healthcare more accessible and efficient.
NCARS provides chain services such as machine repair, body spraying, insurance, and accident vehicle. They offer brand marketing management, accessories supply chain, technician training, and service management.
Rakunew
Corporate Round in 2015
Rakunew is an e-commerce company that offers a range of gadgets and new products that are popular overseas. The company is an international mail-order company that sells innovative household items and gadgets that are well-liked abroad but hard to find in Japan.
Zhangshang Tangyi
Series A in 2015
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.
58 Daojia
Series A in 2015
58 Daojia operates an online platform that offers access to various high-quality household services, including cleaning, moving, babysitting, and beauty care, across approximately 30 cities in China. Founded in September 2014, the platform utilizes a location-based order processing system to efficiently connect users with independent service providers nearby. This approach enables customers to easily access a range of essential services, facilitating a more comfortable home life.
Clinicloud
Seed Round in 2015
CliniCloud, Inc. is a healthcare technology company based in San Francisco, California, founded by physicians Dr. Hon Weng Chong and Dr. Andrew Lin. The company develops a connected medical kit designed to empower users to monitor their health conditions actively. This kit includes a digital stethoscope and a non-contact thermometer, complemented by a mobile application that records high-fidelity audio of heart and respiratory sounds. The application provides users with vital metrics such as respiratory rate and heart rate, allowing them to identify any irregularities. By equipping individuals with these tools, CliniCloud aims to enhance patient engagement in healthcare decisions and facilitate timely evaluations by professionals. The company's commitment to innovation is evident through its continuous development of software and devices that aim to bring advanced healthcare capabilities into the home.
Ativa Medical
Series B in 2015
Ativa Medical Corporation is a medical device manufacturing company based in Saint Paul, Minnesota, founded in 2008. The company specializes in developing and commercializing point of care testing medical diagnostics products aimed at decentralized healthcare settings. Ativa Medical focuses on providing rapid diagnostic test results for critical hematology and clinical chemistry tests, utilizing advanced microfluidics technology. Its product offerings include analyzers and disposable test cards designed for trauma, pediatric, oncology, and geriatric patients. These products cater to various healthcare environments, including hospital departments, physician's offices, and remote healthcare clinics, enhancing the speed and accessibility of medical diagnostics.
Payoneer Inc., established in 2005, operates a global cross-border payments platform. It facilitates international transactions for businesses, enabling them to receive local bank transfers and funds from various marketplaces and partners directly to their Payoneer account or bank account. The company offers services such as the Global Payment Service, which provides access to multiple receiving accounts in the U.S., EU, and Japan, and mass payout services for Indian companies. Payoneer caters primarily to freelancers, e-commerce, and online advertising industries, and has strategic partnerships with several companies. It is headquartered in New York, New York.
Beijing Express Channel Cold Chain Logistics Co.
Series A in 2015
Beijing Express Channel Cold Chain Logistics Co., Ltd., located in Beijing, China, specializes in providing logistics solutions with a focus on cold chain services. The company offers a range of logistics options, including cold chain urban distribution, cold chain less-than-truckload services, and cold chain home delivery. By emphasizing economical and suitable cold chain logistics solutions, Beijing Express Channel aims to meet the diverse needs of its customers, ensuring the safe and efficient handling of temperature-sensitive products throughout the supply chain.
Secoo is a luxury products and services platform based in China, facilitating global trade between buyers and suppliers through both online and offline channels. The company operates an online retail platform and experience centers in key cities such as Beijing, Shanghai, Chengdu, and others, as well as in Malaysia. Secoo collaborates with renowned brand boutiques, allowing customers to pick up products ordered online at physical locations. The majority of its revenue is derived from its online business, with a significant focus on the Chinese market. Established in 2011, Secoo has built a substantial membership base of 500,000, including over 20,000 VIP members. The company aims to enhance its presence by establishing exhibition centers in major cities, further solidifying its position in the luxury retail sector.
Didi
Private Equity Round in 2015
Didi Chuxing, founded in 2012 in Beijing, is a leading mobile transportation platform providing app-based services such as taxi hailing, private car-hailing, social ride-sharing, car rental, and enterprise solutions. With over 450 million users and daily orders reaching 25 million, Didi offers a variety of mobility options to optimize resource allocation through big data-driven algorithms. The company aims to address transportation, environmental, and employment challenges by collaborating with communities and partners. Acquiring Uber China in 2016, Didi has over 21 million drivers and car owners on its platform, generating income while offering convenient transportation solutions to users worldwide.
Bochewang
Series A in 2015
Bochewang operates as a professional B2B trading platform focused on motor cars and accessories, catering specifically to professional buyers such as auto repair shops, dismantle shops, used car dealers, and parts sellers. The platform features three primary components: an auction center for selling accident and used vehicles, an automobile showroom for trading repaired cars, and an accessories platform for various auto parts. By facilitating online transactions, Bochewang aims to streamline the buying and selling process for car owners and buyers, enhancing efficiency while reducing the time involved in these transactions. Users can access a variety of services and rights upon completing registration, payment, and authentication on the platform.
Beijing Rogrand Electronic Commerce Co., Ltd. is a private company established in 2012, specializing in medical e-commerce integrated services in China. The firm operates as a comprehensive service platform that encompasses the entire pharmaceutical industry chain, facilitating connections among pharmaceutical companies, pharmacies, clinics, and medical institutions. Rogrand aims to innovate within the pharmaceutical sector by providing a circulation platform that enhances the efficiency and effectiveness of medical commerce, ultimately contributing to the overall advancement of healthcare services in the region.
Purple Clinic
Series A in 2015
Purple Clinic is a provider of a WeChat-based doctor-patient service platform that addresses the specific needs of medical partners. The company has developed a digital marketing project management platform focused on enhancing communication between healthcare providers and patients. Its online medical mobile application facilitates consultations in various medical fields, including dermatology, pediatrics, gynecology, andrology, and internal medicine. By streamlining interactions and offering tailored solutions, Purple Clinic aims to improve the efficiency and effectiveness of medical service delivery.
Medbanks Network Technology, based in Beijing and founded in 2014, specializes in data processing services tailored for the healthcare sector. The company focuses on developing an oncology database that consolidates clinical and professional medical services, leveraging information collected from hospitals. This initiative enhances the availability of critical data for healthcare providers and researchers. Medbanks plays a significant role in supporting the healthcare industry's need for accurate and comprehensive medical information, thereby contributing to advancements in patient care and treatment methodologies.
eXiche provide users with Internet booking to the shop car wash, door car wash services.
9F Group is a Chinese fintech platform established in 2006, boasting over 68 million registered users, primarily utilizing its mobile applications. The company offers a diverse array of financial services, including online lending, wealth management, and payment facilitation, all accessible through a personalized digital financial account. Its various brands, such as 9F Onecard, 9F Wallet, Wukong Wealth, and Wecash, cater to the financial needs of users throughout different life stages. 9F Group emphasizes the use of mobile Internet and big data risk management technologies to enhance service efficiency and quality. Additionally, the company has invested in over ten internet finance startups to explore future technological advancements. As a founding member and board member of the National Internet Finance Association of China, 9F is actively involved in shaping the regulatory landscape of the fintech industry in the country. The majority of its revenue is derived from loan facilitation services within China.
Rainbow Medical Innovation
Venture Round in 2015
Rainbow Medical Innovation is a private operational company established in 2007 and based in Herzliya, Israel. It focuses on seeding and developing companies that create innovative medical devices, primarily those invented by Yossi Gross. The company aims to address significant unmet needs in various medical fields, contributing to advancements in healthcare while fostering the growth of its portfolio companies. By concentrating on breakthrough technologies, Rainbow Medical Innovation seeks to deliver substantial returns for its investors.
Trina Solar
Convertible Note in 2015
Trina Solar Co., Ltd. is an integrated manufacturer of solar power products and a developer of solar systems, with operations spanning China, Europe, the United States, and other regions in Asia Pacific. Established in 1997 and headquartered in Changzhou, China, the company specializes in designing, manufacturing, and selling a range of photovoltaic (PV) modules, including monocrystalline and multicrystalline types, suitable for residential, commercial, and industrial applications. Trina Solar also produces silicon ingots, wafers, and cells, and offers services related to the construction and management of solar power projects. The company serves a diverse clientele that includes power plant developers, distributors, and grid operators, positioning itself as a significant player in both the domestic and global solar markets. Additionally, Trina Solar is involved in smart energy solutions, encompassing the operation and management of photovoltaic power stations and the development of smart microgrid systems.
WanJiangLong
Series A in 2015
WanJiangLong operates in the fields of internet services and commercial real estate. The company provides comprehensive operational solutions that support various stages of commercial real estate, including construction, opening, and ongoing operations. Its services are designed to assist commercial complexes in attracting new customers, enhancing engagement, retaining clientele, and ultimately boosting sales. Additionally, WanJiangLong has developed consumer data collection and analysis software that aids shopping center merchants in identifying customer preferences. This technology facilitates the creation of customized marketing strategies, enabling businesses to expand their customer base and improve overall sales performance.
Mogoroom currently operates in Shanghai and Beijing, providing standardized rental apartments to young professionals seeking more convenient living environment services.
Qiaobu Jianli
Series A in 2014
Qiaobu Jianli provides online portal services for resume templates to students. They offer black and white resume templates and colour resume templates. Thye also offer industries related resume templates such as communication , biology, pharmaceutical, civil engineering.
eToro is a global multi-asset investment platform founded in 2007, based in London. It empowers individuals to grow their knowledge and wealth by providing a social trading network that allows users to trade various assets including currencies, commodities, indices, crypto assets, and stocks. eToro's platform enables users to manually invest in different asset classes or automatically copy the trades of other successful traders within its community of over 23 million registered users. The company operates as a subsidiary of eToro Group Limited.
Black & White Campus
Angel Round in 2014
Black & White Campus is a company focused on enhancing student engagement through its mobile social application. The app serves as a platform for students to connect, discuss various topics, and organize meetups. Additionally, the company specializes in campus promotion activities, facilitating events and initiatives that foster community interaction and collaboration among students. By addressing the social needs of the student population, Black & White Campus aims to create a vibrant and connected campus experience.